Rockefeller Capital Management L.P. Meridian Bioscience Inc Transaction History

Rockefeller Capital Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$30.9 - $33.55 $2,688 - $2,918	-87 Reduced 4.13%	2,018 $63,000
Q2 2022 Aug 12, 2022	BUY	$23.75 - $31.69 $2,493 - $3,327	105 Added 5.25%	2,105 $64,000
Q2 2021 Aug 10, 2021	BUY	$18.01 - $28.32 $36,020 - $56,640	2,000 New	2,000 $44,000
Q2 2019 Aug 09, 2019	SELL	$10.88 - $17.6 $3,046 - $4,928	-280 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$15.51 - $17.61 $4,342 - $4,930	280 New	280 $5,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.